CITF Research Results

CITF Research Results2023-10-27T10:53:53-04:00

Omicron breakthrough infection induces superior mucosal and humoral immunity to SARS-CoV-2 variants than booster vaccination

A CITF-funded study that presented results at the CITF scientific meeting in Vancouver, found that an Omicron breakthrough infection (an infection after a full vaccine series) induces a stronger overall immune response than booster vaccination alone. Both mucosal and humoral immunity contribute to the overall immune response to SARS-CoV-2.

July 12, 2023|Immune science|

SARS-CoV-2 seroepidemiologic studies need to improve reporting

A CITF-funded study, published in preprint and not yet peer-reviewed, found that the reporting of SARS-CoV-2 seroepidemiologic studies needs improvement, particularly in providing adequately detailed information about laboratory methods. Researchers showed that there was a median adherence to reporting items of 48% per study, as evaluated via the Reporting of Seroepidemiologic studies—SARS-CoV-2 (ROSES-S) guideline.

July 12, 2023|Seroprevalence studies|

Virtual care technologies during the COVID-19 pandemic changed how healthcare was received among Canadian gay, bisexual and queer men

A CITF-funded study, published in Sociology of Health and Illness, discovered that virtual care (healthcare at home using mainly telephone consultations) not only helps with delivering and receiving medical care but also brings about changes in the ways that people interact and provide care.

July 12, 2023|2LGBTQ2+, Geographic & priority populations|
Go to Top